Exploiting research results in clinical practice is far more complex in biomedicine than in other areas. That is because we are talking about human health – the most fundamental value of each of us. Therefore, an element of caution is appropriate – a number of laboratory tests and clinical studies are required to demonstrate that the product is safe and reasonably effective for humans. The ” from laboratory to patient” journey is long and requires many experienced experts from various fields, entire teams of experts, to be successful. Of course, this is neither simple nor cheap.
And that is why CZECRIN is here. CZECRIN is an expert research infrastructure, composed of experts from all areas and segments of the drug development lifecycle. The availability of this expertise – both physical and financial – is key to enabling the use of biomedical research in clinical practice.